Viking Therapeutics, Inc. (VKTX) Prices Upsized $500M Stock and 2.00% Convertible Notes

Viking priced 7,857,143 shares at $35 for ~$275M and $225M of 2.00% convertible notes due 2032; initial conversion price is ~$50.75. Closings expected Sept. 25, 2026, subject to conditions.Material DetailsContext by AI AnalystThis is a capital raise to fund late-stage obesity and metabolic programs…